Phase 2 Nilotinib Trials for Parkinsonʼs Yield Conflicting Efficacy Results

Neurology Today
doi 10.1097/01.nt.0000662128.13325.97
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Exposure‐Response Relationships for Efficacy and Safety of Risankizumab in Phase 2 and 3 Trials in Psoriasis Patients

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

A Trivariate Continual Reassessment Method for Phase I/Ii Trials of Toxicity, Efficacy, and Surrogate Efficacy

Statistics in Medicine
EpidemiologyStatisticsProbability
2012English

Neuropsychiatric Safety With Liraglutide 3.0 Mg for Weight Management: Results From Randomized Controlled Phase 2 and 3a Trials

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Safety and Efficacy of Pasireotide in Dumping Syndrome-Results From a Phase 2, Multicentre Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

Headache
Neurology
2019English

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Current Diabetes Reviews
EndocrinologyMetabolismDiabetes
2017English

Multicenter Phase II Clinical Trial of Nilotinib for Patients With Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia From the East Japan CML Study Group Evaluation of Molecular Response and the Efficacy and Safety of Nilotinib

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine

BMC Medicine
Medicine
2014English

MDMA-assisted Psychotherapy for Treatment of PTSD: Study Design and Rationale for Phase 3 Trials Based on Pooled Analysis of Six Phase 2 Randomized Controlled Trials

Psychopharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy